v3.26.1
Equity
12 Months Ended
Dec. 31, 2025
Disclosure of classes of share capital [abstract]  
Equity
16.
Equity
(a)
Capital stock and distribution of dividends –

IFS’s shares are listed on the Lima Stock Exchange and, since July 2019, they are listed also on the New York Stock Exchange. IFS’s shares have no nominal value and their issuance value was US$9.72 per share. As of December 31, 2025 and 2024, IFS’s capital stock is represented by 115,447,705 subscribed and paid-in common shares.

 

The General Shareholders’ Meeting of IFS held on March 31, 2026, agreed to distribute dividends charged to profits for the year 2025 for approximately US$207,797,000 (equivalent to S/723,965,000); equivalent to US$1.80 per share, which will be paid on May 5, 2026.

 

The General Shareholders’ Meeting of IFS held on March 31, 2025, agreed to distribute dividends charged to profits for the year 2024 for approximately US$115,443,000 (equivalent to S/420,096,000); equivalent to US$1.00 per share, which were paid on May 5, 2025.

 

The General Shareholders’ Meeting of IFS held on April 1, 2024, agreed to distribute dividends charged to profits for the year 2023 for approximately US$115,443,000 (equivalent to S/427,369,000); equivalent to US$1.00 per share, which were paid on April 29, 2024.

 

The General Shareholders’ Meeting of IFS held on March 31, 2023, agreed to distribute dividends charged to profits for the year 2022 for approximately US$136,222,000 (equivalent to S/511,788,000); equivalent to US$1.18 per share, which were paid on May 8, 2023.

(b)
Treasury stock -

On March 31, 2023, IFS’s shareholders approved the Share Repurchase Program. This program authorized the acquisition of up to US$100 million of common shares, being carried out simultaneously on the Bolsa de Valores de Lima (BVL) and the New York Stock Exchange (NYSE), on one or more dates and at market prices. The program remained in effect until April 17, 2025. Within the framework of this Program, as of December 31, 2025 Interbank holds a total of 3,618,000 shares with an approximate value of S/372,017,000. During the years 2025, 2024 and 2023, Interbank acquired 1,488,000, 1,192,000 and 938,000 shares. The approximate amounts of these acquisitions were S/168,308,000, S/122,688,000 and S/81,021,000, respectively.

On March 31, 2025, IFS’s shareholders approved a new Share Repurchase Program, maintaining a limit of up to US$100 million of common shares under the same conditions as the previous program. This new program will remain in effect until the Board of Directors decides otherwise. Within this new Program, as of December 31, 2025, Interbank holds 700,000 shares with an approximate value of S/91,915,000.

 

In 2025, Inteligo acquired 18,000 shares of IFS, at market value, for an amount of approximately US$656,000 (equivalent to approximately S/2,326,000).

 

In 2024, Interfondos acquired 2,000 common shares of IFS, at market value, for an amount of approximately US$45,000 (equivalent to approximately S/169,000). On November 20, 2024, Interfondos sold these shares.

 

As of December 31, 2025 and 2024, the Company and some Subsidiaries, all together, hold 4,365,000 and 2,159,000 shares issued by IFS, with an acquisition cost of US$127,821,000 (equivalent to S/469,546,000) and US$55,704,000 (equivalent to S/206,997,000), respectively.

(c)
Capital surplus -

Corresponds to the difference between the nominal value of the shares issued and their public offerings price, which were performed in 2007 and 2019. Capital surplus is presented net of the expenses incurred and related to the issuance of such shares.

(d)
Unrealized results, net -

This item is made up as follows:

 

 

 

Unrealized gain (loss)

 

 

 

Instruments that will not be reclassified to consolidated statement of income

 

 

Instruments to be reclassified to the consolidated
statement of income

 

 

 

 

 

 

Equity instruments at fair value

 

 

Debt instruments at fair value

 

 

Insurance contracts reserve

 

 

Cash flow
hedge reserve

 

 

Translation of foreign operations

 

 

Total

 

 

 

S/(000)

 

 

S/(000)

 

 

S/(000)

 

 

S/(000)

 

 

S/(000)

 

 

S/(000)

 

Balances as of January 1, 2023

 

 

(46,763

)

 

 

(2,420,809

)

 

 

1,711,493

 

 

 

(9,262

)

 

 

210,920

 

 

 

(554,421

)

Effect of changes in the discount rates of pension reserves, Note 3.4(d)

 

 

 

 

 

 

 

 

(968,599

)

 

 

 

 

 

 

 

 

(968,599

)

Unrealized gain from equity instruments at fair value through other comprehensive income, net of unrealized loss

 

 

16,055

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

16,055

 

Transfer to retained earnings from realized gain from equity instruments at fair value through other comprehensive income, Note 5(g)

 

 

(33,433

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(33,433

)

Unrealized gain from debt instruments at fair value through other comprehensive income, net of unrealized loss

 

 

 

 

 

1,128,206

 

 

 

 

 

 

 

 

 

 

 

 

1,128,206

 

Transfer to realized gain from debt instruments at fair value through other comprehensive income, net of realized loss

 

 

 

 

 

(8,350

)

 

 

 

 

 

 

 

 

 

 

 

(8,350

)

Transfer of impairment on debt instruments at fair value through other comprehensive income

 

 

 

 

 

7,390

 

 

 

 

 

 

 

 

 

 

 

 

7,390

 

Variation for net unrealized loss on cash flow hedges

 

 

 

 

 

 

 

 

 

 

 

(67,980

)

 

 

 

 

 

(67,980

)

Transfer of realized loss on cash flow hedges to consolidated statement of income, net of realized gain

 

 

 

 

 

 

 

 

 

 

 

45,309

 

 

 

 

 

 

45,309

 

Translation of foreign operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(21,970

)

 

 

(21,970

)

Balances as of December 31, 2023

 

 

(64,141

)

 

 

(1,293,563

)

 

 

742,894

 

 

 

(31,933

)

 

 

188,950

 

 

 

(457,793

)

Effect of changes in the discount rates of pension reserves

 

 

 

 

 

 

 

 

(61,299

)

 

 

 

 

 

 

 

 

(61,299

)

Unrealized gain from equity instruments at fair value through other comprehensive income, net of unrealized loss

 

 

1,263

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,263

 

Transfer to retained earnings from realized loss from equity instruments at fair value through other comprehensive income, Note 5(g)

 

 

53,737

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

53,737

 

Unrealized gain from debt instruments at fair value through other comprehensive income, net of unrealized loss

 

 

 

 

 

259,523

 

 

 

 

 

 

 

 

 

 

 

 

259,523

 

Transfer to realized gain from debt instruments at fair value through other comprehensive income, net of realized loss

 

 

 

 

 

(25,325

)

 

 

 

 

 

 

 

 

 

 

 

(25,325

)

Transfer of impairment on debt instruments at fair value through other comprehensive income

 

 

 

 

 

47,497

 

 

 

 

 

 

 

 

 

 

 

 

47,497

 

Variation for net unrealized loss on cash flow hedges

 

 

 

 

 

 

 

 

 

 

 

(57,848

)

 

 

 

 

 

(57,848

)

Transfer of realized loss on cash flow hedges to consolidated statement of income, net of realized gain

 

 

 

 

 

 

 

 

 

 

 

40,668

 

 

 

 

 

 

40,668

 

Translation of foreign operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11,747

 

 

 

11,747

 

Balances as of December 31, 2024

 

 

(9,141

)

 

 

(1,011,868

)

 

 

681,595

 

 

 

(49,113

)

 

 

200,697

 

 

 

(187,830

)

Effect of changes in the discount rates of pension reserves

 

 

 

 

 

 

 

 

(735,284

)

 

 

 

 

 

 

 

 

(735,284

)

Unrealized gain from equity instruments at fair value through other comprehensive income, net of unrealized loss

 

 

69,079

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

69,079

 

Unrealized gain from debt instruments at fair value through other comprehensive income, net of unrealized loss.

 

 

 

 

 

730,337

 

 

 

 

 

 

 

 

 

 

 

 

730,337

 

Transfer to realized gain from debt instruments at fair value through other comprehensive income, net of realized loss.

 

 

 

 

 

(101,536

)

 

 

 

 

 

 

 

 

 

 

 

(101,536

)

Transfer of impairment on debt instruments at fair value through other comprehensive income

 

 

 

 

 

263,368

 

 

 

 

 

 

 

 

 

 

 

 

263,368

 

Variation for net unrealized gain on cash flow hedges

 

 

 

 

 

 

 

 

 

 

 

92,950

 

 

 

 

 

 

92,950

 

Transfer of realized gain on cash flow hedges to consolidated statement of income, net of realized loss

 

 

 

 

 

 

 

 

 

 

 

(53,046

)

 

 

 

 

 

(53,046

)

Translation of foreign operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(101,063

)

 

 

(101,063

)

Other movements

 

 

(13,009

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(13,009

)

Balances as of December 31, 2025

 

 

46,929

 

 

 

(119,699

)

 

 

(53,689

)

 

 

(9,209

)

 

 

99,634

 

 

 

(36,034

)

(e)
Components of other comprehensive income -

The consolidated statement of comprehensive income includes: (i) other comprehensive income that will not be reclassified to the consolidated statement of income in future periods, such as the revaluation of gain (loss) in equity instruments at fair value through other comprehensive income; which will not be reclassified to the consolidated statement of income at the time of its disposal, but will be reclassified to retained earnings; and (ii) other comprehensive income to be reclassified to the consolidated statement of income in future periods, such as the comprehensive income of financial instruments derivatives used as cash flow hedges, debt instruments at fair value through other comprehensive income and translation for foreign operations. Below is the movement of the caption:

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

S/(000)

 

 

S/(000)

 

 

S/(000)

 

Other comprehensive income that will not be reclassified to the consolidated statement of income in future periods:

 

 

 

 

 

 

 

 

 

Equity instruments at fair value through other comprehensive income

 

 

 

 

 

 

 

 

 

Gains on equity instruments at fair value through other comprehensive income, net

 

 

69,079

 

 

 

1,263

 

 

 

16,055

 

Subtotal

 

 

69,079

 

 

 

1,263

 

 

 

16,055

 

Non-controlling interest

 

 

690

 

 

 

190

 

 

 

8

 

Income Tax

 

 

183

 

 

 

1,595

 

 

 

157

 

Total

 

 

69,952

 

 

 

3,048

 

 

 

16,220

 

Other comprehensive income to be reclassified to the consolidated statement of income in future periods:

 

 

 

 

 

 

 

 

 

Debt instruments at fair value through other comprehensive income

 

 

 

 

 

 

 

 

 

Net gain unrealized on debt instruments at fair value through other comprehensive income

 

 

730,337

 

 

 

259,523

 

 

 

1,128,206

 

Transfer to income of net realized gain on debt instruments at fair value through other comprehensive income

 

 

(101,536

)

 

 

(25,325

)

 

 

(8,350

)

Transfer to income of loss for impairment on debt instruments at fair value through other comprehensive income

 

 

263,368

 

 

 

47,497

 

 

 

7,390

 

Subtotal

 

 

892,169

 

 

 

281,695

 

 

 

1,127,246

 

Non-controlling interest

 

 

2,506

 

 

 

1,448

 

 

 

3,618

 

Income Tax

 

 

4,129

 

 

 

3,595

 

 

 

3,645

 

Total

 

 

898,804

 

 

 

286,738

 

 

 

1,134,509

 

Insurance contracts reserve at fair value

 

 

(735,284

)

 

 

(61,299

)

 

 

(968,599

)

Non-controlling interest

 

 

(1,082

)

 

 

(90

)

 

 

(1,592

)

Total

 

 

(736,366

)

 

 

(61,389

)

 

 

(970,191

)

Cash flow hedges:

 

 

 

 

 

 

 

 

 

Net gain (loss) from cash flow hedges

 

 

92,950

 

 

 

(57,848

)

 

 

(67,980

)

Transfer of net realized (gain) loss from cash flow hedge to consolidated statement of income

 

 

(53,046

)

 

 

40,668

 

 

 

45,309

 

Subtotal

 

 

39,904

 

 

 

(17,180

)

 

 

(22,671

)

Non-controlling interest

 

 

109

 

 

 

(23

)

 

 

(105

)

Income Tax

 

 

6,588

 

 

 

(1,402

)

 

 

(6,336

)

Total

 

 

46,601

 

 

 

(18,605

)

 

 

(29,112

)

Foreign currency translation

 

 

(101,063

)

 

 

11,747

 

 

 

(21,970

)

 

(f)
Shareholders’ equity for legal purposes (regulatory capital) -

Within the framework of the Consolidated Supervision regulated by the SBS through the Regulation for the Consolidated Supervision of Financial and Mixed Conglomerates, approved by SBS Resolution No. 11823-2010 and amendments, the Intercorp Group must meet certain capital requirements as well as global and concentration limits, among other requirements, applicable to its Financial Group, which is defined by the SBS. As of December 31, 2025 and 2024, the Financial Group is comprised of Intercorp Financial Services Inc., its subsidiaries and InFinance XP S.A. (formerly Financiera Oh! S.A.), a related entity, subsidiary of Intrecorp Peru.

 

On the other hand, as of December 31, 2025 and 2024, the regulatory capital required for Interbank, Interseguro and Inteligo Bank (a Subsidiary of Inteligo Group Corp.), is calculated based on the separate financial statement of each Subsidiary and prepared following the accounting principles and practices of their respective regulators (the SBS or the Central Bank of the Bahamas, in the case of Inteligo Bank).

 

As of December 31, 2025 and 2024, the Company and its subsidiaries have complied with the capital requirements and complementary provisions established by their regulators for individual and consolidated supervision purposes, as applicable.

The regulatory capital required for Interbank, Interseguro and Inteligo Bank is detailed below:

Interbank’s regulatory capital -

According to Legislative Decree No. 1028 and amendments, Interbank’s regulatory capital must be equal to or higher than 10 percent of the assets and contingent credits weighted by total risk represented by the sum of: the regulatory capital requirement for market risk multiplied by 10, the regulatory capital requirement for operational risk multiplied by 10 and the assets and contingent credits weighted by credit risk. SBS Resolution No. 3952-2022 and its amendments, establishing that within the period between January and March 2023, the regulatory capital for financial companies must be equal or higher than 8.5 percent of the assets and contingent assets weighted by total risks; equal or higher than 9 percent between April 2023 and August 2024; equal or higher than 9.5 percent between September 2024 and February 2025; and higher or equal 10 percent from March 2025 onwards, accordingly, the regulation for the capital requirement for credit risk is also amended, superseding Multiple Official Letter No. 27358-2021-SBS and Emergency Decree No. 003-2022.

 

As of December 31, 2025 and 2024, in application of the current SBS Resolutions, Interbank maintains the following amounts related to the risk weighted assets and contingent and regulatory capital (basic and supplementary):

 

 

 

2025

 

 

2024

 

 

 

S/(000)

 

 

S/(000)

 

Total risk weighted assets and credits

 

 

69,129,765

 

 

 

64,308,282

 

Total regulatory capital

 

 

11,076,092

 

 

 

10,239,304

 

Basic regulatory capital (Level 1)

 

 

8,641,287

 

 

 

7,892,361

 

Supplementary regulatory capital (Level 2)

 

 

2,434,805

 

 

 

2,346,943

 

Global capital to regulatory capital ratio

 

 

16.02

%

 

 

15.92

%

 

As of December 31, 2025 and 2024, Interbank has complied with SBS Resolutions No.2115-2009, No.6328-2009, No.14354-2009, No.4128-2014, “Regulations for the Regulatory Capital Requirement for Operational Risk”, “Market Risk” and “Credit Risk”, respectively, and their amendments. These resolutions establish, mainly, the methodologies to be applied by financial entities to calculate the assets and credits weighted per type of risk.

 

SBS Resolution No. 3953-2022 establishes the calculation of the regulatory capital requirement for additional risks, which shall be equal to the sum of the regulatory capital requirements for concentration risk plus the regulatory capital requirements of interest rate risk in the banking book, repealing SBS Resolution No. 8425-2011. As of December 31, 2025 and 2024, the regulatory capital requirement for additional risks is approximately S/829,445,000 and S/731,841,000, respectively.

 

Interseguro’s regulatory capital -

In accordance with SBS Resolution No. 1124-2006, and its amendments, Interseguro is required to maintain a level of regulatory capital to maintain a minimum equity to support technical risks and other risks that could affect it. The regulatory capital must be higher than the amount resulting from the sum of the solvency net equity, the guarantee fund and the regulatory capital intended to cover credit risks.

 

The solvency net equity is represented by the higher amount between the solvency margin and the minimal capital. As of December 31, 2025 and 2024, the solvency net equity is represented by the solvency margin. The solvency margin is the complementary support that insurance entities must maintain to deal with possible situations of excess claims not foreseen in the establishment of technical reserves. The total solvency margin corresponds to the sum of the solvency margins of each branch in which Interseguro operates.

 

Also, the guarantee fund represents the additional equity support that insurance companies must maintain to deal with the other risks that can affect them and that are not covered by the solvency net equity, such as investment risks and other risks. The monthly amount of said fund must be equivalent to 35 percent of the solvency net equity, calculated in accordance with SBS Resolution No. 1124-2006 and its amendments.

As of December 31, 2025 and 2024, Interseguro’s surplus equity is as follows:

 

 

 

2025

 

 

2024

 

 

 

S/(000)

 

 

S/(000)

 

Regulatory capital

 

 

1,657,014

 

 

 

1,509,399

 

Less

 

 

 

 

 

 

Solvency equity (solvency margin)

 

 

750,377

 

 

 

706,926

 

Guarantee fund

 

 

626,067

 

 

 

499,073

 

Surplus

 

 

280,570

 

 

 

303,400

 

 

Inteligo Bank’s regulatory capital –

The Central Bank of the Bahamas requires Inteligo Bank to maintain a regulatory capital of not less than 8 percent of its risk weighted assets. Inteligo Bank’s capital ratio as of December 31, 2025 and 2024 is the following:

 

 

 

2025

 

 

2024

 

 

 

US$(000)

 

 

US$(000)

 

Total eligible capital

 

 

184,221

 

 

 

157,178

 

Total risk weighted assets

 

 

847,099

 

 

 

812,526

 

Capital adequacy ratio (in percentage)

 

 

21.75

 

 

 

19.34

 

 

In Management’s opinion, IFS and its Subsidiaries have complied with the requirements set forth by the regulatory entities.

(g)
Reserves -

The Board of Directors’ Meeting of IFS held on March 31, 2025, agreed to constitute reserves for S/800,000,000 charged to retained earnings.

 

The Board of Directors’ Meeting of IFS held on November 12, 2024, agreed to constitute reserves for S/2,300,000,000 charged to retained earnings.

(h)
Subsidiaries’ legal and special reserves -

In accordance with Peruvian regulations, the Subsidiaries domiciled in Peru are required to establish a reserve equivalent to a certain percentage of their paid-in capital (20 or 35 percent, depending on their economic activity) through annual transfers of not less than 10 percent of their net income. As of December 31, 2025 and 2024, the reserves constituted by the Peruvian subsidiaries amounted to S/1,893,313,000 and S/1,779,383,000, respectively.